BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27881153)

  • 1. Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma.
    Feng J; Lan R; Cai G; Lin J; Wang X; Lin J; Han D
    J Orthop Surg Res; 2016 Nov; 11(1):150. PubMed ID: 27881153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.
    Xie Y; Huang J; Wu M; Zhou Y
    J Cancer Res Ther; 2018; 14(4):892-895. PubMed ID: 29970672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREX1 suppression imparts cancer-stem-cell-like characteristics to CD133
    Feng J; Lan R; Cai G; Lin J
    Int J Clin Exp Pathol; 2019; 12(4):1134-1153. PubMed ID: 31933929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
    Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
    Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.
    Yong BC; Lu JC; Xie XB; Su Q; Tan PX; Tang QL; Wang J; Huang G; Han J; Xu HW; Shen JN
    Tumour Biol; 2017 Feb; 39(2):1010428317691188. PubMed ID: 28240050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma.
    Liang W; Yang C; Peng J; Qian Y; Wang Z
    Cell Biochem Biophys; 2015 Dec; 73(3):763-8. PubMed ID: 27259322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Zhang M; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
    Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
    Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
    Huang Y; Dai H; Guo QN
    Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
    Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
    FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
    Wu H; Zhang J; Dai R; Xu J; Feng H
    J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
    Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
    BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
    Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
    Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.